ImmunityBio (IBRX) Acquisitions (2015)

ImmunityBio's (IBRX) quarterly Acquisitions came in at $1.8 million in Q1 2015.

ImmunityBio (IBRX) Acquisitions (2015) Analysis & Trends

ImmunityBio (IBRX) has 1 years of Acquisitions data on file, last reported at $1.8 million in Q1 2015.

On a quarterly basis, Acquisitions changed N/A year-over-year to $1.8 million in Q1 2015; TTM through Dec 2015 was $1.8 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.0 million, changed N/A from the prior year.
Acquisitions for Q1 2015 stood at $1.8 million.
Over the last five years, Acquisitions for IBRX reached as high as $1.8 million in Q1 2015 and fell as low as $1.8 million in Q1 2015.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	ImmunityBio	7.60 Bn	7.22 Bn	43.97 Mn	-

Historic Data

Download Data

Date	Value
Mar 31, 2015	1.82 Mn